Galectin Therapeutics
GALT
GALT
78 hedge funds and large institutions have $28.8M invested in Galectin Therapeutics in 2019 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 25 increasing their positions, 10 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
20% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 10
48% less call options, than puts
Call options by funds: $453K | Put options by funds: $865K
Holders
78
Holding in Top 10
–
Calls
$453K
Puts
$865K
Top Buyers
| 1 | +$819K | |
| 2 | +$329K | |
| 3 | +$246K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$212K |
| 5 |
VF
Virtu Financial
New York
|
+$157K |
Top Sellers
| 1 | -$123K | |
| 2 | -$111K | |
| 3 | -$88K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$86.5K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$60K |